Clinical efficiency and tolerability of the new detoxifying agent “Neoreodez” in patient with acute peritonitis

Makarenko, O.V. and Kuzminykh, S.S. (2018) Clinical efficiency and tolerability of the new detoxifying agent “Neoreodez” in patient with acute peritonitis. Modern Science — Moderní věda, 3. pp. 108-114. ISSN 2336-498X

[img]
Preview
Text
2-Clinical efficiency and tolerability of “Neoreodez”.pdf

Download (3MB) | Preview

Abstract

In a clinical study, it has been shown that the use of drug "Neoreodez", a solution for infusion of 200 ml and 400 ml as a component of basic therapy significantly increases the effectiveness of treatment in patients with acute peritonitis compared with the administration of basic therapy only. Registered efficacy in the main group of patients receiving Neoreodez was 94.2%, that is significantly higher than the control group - 52.0%. Thus, the hypothesis regarding the excess of treatment efficacy in the main group of patients as compared to the control group has been confirmed.

Item Type: Article
Uncontrolled Keywords: clinical efficacy, acute peritonitis, detoxifying therapy, "Neoreodez".
Subjects: Clinical Pharmacology
Divisions: Faculty of Postgraduate Education > Department of social medicine, public health and health care management
Depositing User: Оксана Мажуга
Date Deposited: 17 Feb 2020 09:41
Last Modified: 17 Feb 2020 09:41
URI: http://repo.dma.dp.ua/id/eprint/4971

Actions (login required)

View Item View Item